Alexandria Oliver

Papers

Total Citations

H-Index

About

Alexandria Oliver is a rising figure in neuro-oncology and stereotactic radiosurgery, whose work focuses on optimizing treatment strategies for patients with brain metastases, particularly those arising from melanoma. Her most cited study, "Radiosurgery fractionation and post-treatment hemorrhage development for intact melanoma brain metastases" (2022, 9 citations), addresses a critical clinical challenge: managing the high risk of hemorrhage in melanoma brain lesions after radiosurgery. By investigating how different fractionation schedules influence bleeding complications, Oliver has provided early but impactful evidence that can guide safer, more personalized radiation planning. This contribution is especially significant given melanoma's notorious tendency to bleed, and her findings help refine the balance between tumor control and adverse events. Though early in her career, Oliver's work demonstrates a clear commitment to improving outcomes in a difficult-to-treat patient population. Her research is already informing clinical decision-making and setting the stage for larger prospective studies. For students and clinicians interested in the intersection of radiation oncology and neuro-oncology, Oliver’s focused, patient-centered approach offers a valuable model for translating technical dosimetric considerations into tangible clinical benefits.